AU4529897A - Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine - Google Patents

Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Info

Publication number
AU4529897A
AU4529897A AU45298/97A AU4529897A AU4529897A AU 4529897 A AU4529897 A AU 4529897A AU 45298/97 A AU45298/97 A AU 45298/97A AU 4529897 A AU4529897 A AU 4529897A AU 4529897 A AU4529897 A AU 4529897A
Authority
AU
Australia
Prior art keywords
sibutramine
disorders
compositions
methods
optically pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU45298/97A
Other versions
AU721924B2 (en
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU45428/93A external-priority patent/AU4542893A/en
Application filed by Sepracor Inc filed Critical Sepracor Inc
Priority to AU45298/97A priority Critical patent/AU721924B2/en
Publication of AU4529897A publication Critical patent/AU4529897A/en
Application granted granted Critical
Publication of AU721924B2 publication Critical patent/AU721924B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU45298/97A 1992-06-23 1997-11-21 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine Ceased AU721924B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU45298/97A AU721924B2 (en) 1992-06-23 1997-11-21 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90304092A 1992-06-23 1992-06-23
US903040 1992-06-23
AU45428/93A AU4542893A (en) 1992-06-23 1993-06-22 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
AU45298/97A AU721924B2 (en) 1992-06-23 1997-11-21 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU45428/93A Division AU4542893A (en) 1992-06-23 1993-06-22 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Publications (2)

Publication Number Publication Date
AU4529897A true AU4529897A (en) 1998-02-05
AU721924B2 AU721924B2 (en) 2000-07-20

Family

ID=25627178

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45298/97A Ceased AU721924B2 (en) 1992-06-23 1997-11-21 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Country Status (1)

Country Link
AU (1) AU721924B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity

Also Published As

Publication number Publication date
AU721924B2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
EP0647134A4 (en) Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine.
AU2287495A (en) Methods and compositions for treating depression and other disorders using optically pure s(+) fluoxetine
AU6904498A (en) Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU5439996A (en) Compositions and methods for treating pain
AU5076890A (en) Cleaning compositions and methods
AU3638893A (en) Artificial spinal disc
AU1173195A (en) Treatment of immunoregulatory disorders
EP0708639A4 (en) Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
AU4668193A (en) Method of treating ophthalmic disorders using tgf-beta
AU2514592A (en) Methods and compositions for modulating g protein action
AU4758093A (en) Method of increasing hair shine and repairing alkaline-damaged hair
AU2260992A (en) Children's sunglasses
AU4596896A (en) Substituted benzamides and radioligand analogs and methods of use
AU3245593A (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
AU2007088A (en) Paraherquamide and dihydroparaherquamide as antiparasitic agents
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
AU6660090A (en) Treatment of depression
AU6599196A (en) Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
EP0711159A4 (en) Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
AU5518694A (en) Treatment of a group of related disorders
AU7602894A (en) Use of 2-deoxycoformycin (pentostatin) for treating cerebral and cardiovascular disorders
AU4529897A (en) Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
AU696392B2 (en) Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
AU6953094A (en) Methods and compositions for treating depression and other psychiatric disorders

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)